Professor Chris Goodnow of JCSMR.
Professor Christopher Goodnow of The John Curtin School of Medical Research at ANU is to lead a new five-year project worth more than $15 million looking at inflammatory and immunodeficiency diseases. Professor Goodnow, Director of the Australian Phenomics Facility and Director of the Immunogenomics Laboratory, will lead the project titled 'Molecular and cellular basis of inflammatory and immunodeficiency diseases'. The funding of more than $15 million over five years is through the National Health and Medical Research Council (NHMRC) Program Grants and was announced on Tuesday by Minister for Mental Health and Ageing The Hon Mark Butler MP. The funds will support groundbreaking research by a multi-institutional team of eight chief investigators and more than 40 full-time researchers at ANU and the Canberra Hospital, at the Garvan Institute in Sydney and at Monash University in Melbourne. The team spans disciplines of clinical and experimental immunology, therapeutics, signalling and genetics, and will work to identify how immune and inflammatory responses are controlled in both health and disease. The major outcomes of this work will be the generation of new knowledge, concepts and approaches to diagnose, prevent and treat the major health problems of autoimmune diseases, inflammation, allergy and immunodeficiency. NHMRC Program Grants provide support for teams of the highest quality researchers to drive their own five-year research projects to address complex health problems.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
